Univo Pharmaceuticals

Medical Cannabis Products

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
Univo Pharmaceuticals
03/03/2021
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: pharmacological drugs (Developing drugs)
01/01/1993
"11-50"

Univo Pharmaceuticals is a vertically integrated medical cannabis company focused on the cultivation, manufacture, distribution, and creation of products and dosage forms for medical cannabis products. The company holds initial licenses for the entire supply chain, including growing, breeding, and nursery; production of medical cannabis products; research and development; and distribution.



Univo produces its own cannabis by way of a partnership with Amit Farms, which is located in the south of Israel and designated for cannabis growth. The farm uses innovative agricultural technologies to grow high-quality cannabis and develop Univo's strains to meet specific therapeutic needs.



Univo's IMC-GMP manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. Univo uses ethanol- and CO2-based extraction technologies to manufacture a wide range medical cannabis products. Additional technologies will be added to enable different delivery systems and dosages to meet the needs of products in its R&D pipeline. Univo also packages flowers and distributes them from its facility directly to pharmacies.